- Home
- SEGG vs CRIS Comparison
SEGG vs CRIS Comparison
Compare SEGG & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.22
HOLD
Current Price
$0.43
Company Overview
Basic Information| Metric | SEGG | CRIS |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United States |
| Employees | 12 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 20.6M |
| IPO Year | 2023 | 2000 |
Fundamental Metrics
Financial Performance| Metric | SEGG | CRIS |
|---|---|---|
| Price | $1.22 | $0.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $20.00 | $17.00 |
| AVG Volume (30 Days) | ★ 1.9M | 190.9K |
| Earning Date | 05-20-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | $27.10 |
| Revenue Next Year | N/A | $67.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.46 | $0.41 |
| 52 Week High | $7.61 | $2.57 |
Technical Indicators
Market Signals| Indicator | SEGG | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 41.02 | 33.07 |
| Support Level | $0.97 | N/A |
| Resistance Level | $1.66 | $0.57 |
| Average True Range (ATR) | 0.31 | 0.04 |
| MACD | -0.08 | -0.00 |
| Stochastic Oscillator | 11.98 | 13.93 |
Price Performance
Historical Comparison SEGG
CRIS
About SEGG Lottery.com Inc.
Sports Entertainment Gaming Global Corp is a sports, entertainment and gaming group operating digital assets such as Sports.com and Lottery.com. It is focused on immersive fan engagement, ethical gaming and AI-driven live experiences.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.